Neuroscience and Behavioral Physiology

, Volume 38, Issue 1, pp 55–61 | Cite as

Post-traumatic stress disorder in different types of stress (clinical features and treatment)

  • G. M. Rumyantseva
  • A. L. Stepanov


Two types of stress situation were compared: involvement in combat actions and working in the post-Chernobyl atomic energy station clean-up. A total of 30 subjects involved in combat actions (combatants) and 33 clean-up workers were observed for 5–6 years and 15–17 years after involvement in stress situations. Mean ages in the two groups were 27.0 ± 2.8 and 43.7 ± 4.5 years respectively. Clinical features were analyzed in terms of the major criteria of post-traumatic stress disorder (PTSD) — “immersion” in the experience, “avoidance,” “hyperexcitability,” and “social functioning.” There were both common features in the two groups of subjects as well as individual characteristics dependent on the nature of the stress. Patients were treated with Coaxil at a dose of 37.5 mg/day for four weeks. In both groups of patients, Coaxil had the most favorable effects on immersion and hyperexcitability, which improved social adaptation. The “avoidance” symptom was more resistant. These studies lead to the conclusion that Coaxil is an effective agent for the treatment of different types of PTSD.

Key Words

post-traumatic stress disorder (PTSD) dependence on type of extreme situation clinical features of PTSD treatment Coaxil (tianeptine) 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yu. A. Aleksandrovskii et al., “Efficacy and tolerance of Coaxil (tianeptine) in the treatment of post-traumatic stress disorder,” Zh. Nevrol. Psikhiat., 105, No. 11, 24–29 (2005).Google Scholar
  2. 2.
    Yu. A. Aleksandrovskii, The Problem of Post-Traumatic Stress Disorder and Approaches to Treatment [in Russian], Moscow (2005).Google Scholar
  3. 3.
    V. M. Voloshin, “Treatment of chronic post-traumatic stress disorder with the atypical tricyclic antidepressant tianeptine (Coaxil),” Psikhiat. Psikhofarmakoter., 5, 1 (2003).Google Scholar
  4. 4.
    G. M. Rumyantseva, M. O. Lebedeva, T. M. Levina, et al., Chronic Ecological Stress and Post-Traumatic Stress Disorder in Populations Involved in the Chernobyl Nuclear Power Station Disaster. Old and New Problems in Boundary Psychiatry [in Russian], Moscow (1997), pp. 54–66.Google Scholar
  5. 5.
    N. V. Tarabrina, Handbook in the Psychology of Post-Traumatic Stress [in Russian], Piter, St. Petersburg (2001).Google Scholar
  6. 6.
    J. A. Costa e Silva et al., “Placebo-controlled study of tianeptine in major depressive episodes,” Neuropsychobiol., 35, No. 1, 24–29 (1997).Google Scholar
  7. 7.
    L. Davidson and A. Baum, “Chronic stress and posttraumatic stress disorders,” J. Consult. Clin. Psychol., 54, No. 3, 303–308 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    C. Delbende, D. Bunel, G. Tarozzo, et al., “Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis,” Eur. J. Pharmacol., 251, 245–251 (1994).PubMedCrossRefGoogle Scholar
  9. 9.
    B. L. Green, J. D. Lindy, and M. C. Grace, Psychological Effects of Toxic Contamination. Individual and Community Responses to Trauma and Disaster, Cambridge University Press (1994).Google Scholar
  10. 10.
    M. J. Horowitz, D. S. Weiss, and C. Marmar, “Diagnosis of post-traumatic stress disorder,” J. Nerv. Ment. Dis., 175, 276–277 (1987).CrossRefGoogle Scholar
  11. 11.
    R. Lazarus and S. Folkman, Stress, Appraisal and Coping, Springer, New York (1984).Google Scholar
  12. 12.
    V. Novotny and F. Faltus, “Tianeptine and fluoxetine in major depression: a 6-week randomised double-blind study/human,” Psychopharmacology, 17, No. 6, 299–303 (2002).CrossRefGoogle Scholar
  13. 13.
    G. Thomas, “Tianeptine in PTSD: a double-blind study versus placebo. Protocol and methodological issues,” in: 11 World Congress of Psychiatry, Hamburg (1999).Google Scholar
  14. 14.
    H. M. Vyner, “The psychological dimension of health care for patients exposed to radiation and the other invisible environmental contaminants,” Social Sci. Med., 27, 1097–1103 (1988).CrossRefGoogle Scholar
  15. 15.
    L. Waintraub, L. Septien, and P. Azoulay, “Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine,” CNS Drugs, 16, No. 1, 65–75 (2002).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • G. M. Rumyantseva
    • 1
  • A. L. Stepanov
    • 1
  1. 1.V. P. Serbskii State Scientific Center of Social and Forensic PsychiatryMoscow

Personalised recommendations